AMN:NYE-AMN Healthcare Services Inc (USD)

COMMON STOCK | Medical Care Facilities | NYE

Last Closing Price

USD 114.49

Change

+1.59 (+1.41)%

Market Cap

USD 5.19B

Volume

0.19M

Avg Analyst Target

USD 113.40 (-0.95%)

Avg User Target

USD
Average Analyst Rating

Verdict

Fundamental Analysis

Verdict

About

AMN Healthcare Services, Inc. provides healthcare workforce solutions and staffing services to hospitals and healthcare facilities in the United States. The company operates through three segments: Nurse and Allied Solutions, Physician and Leadership Solutions, and Technology and Workforce Solutions. It offers travel nurse staffing under the American Mobile, Onward Healthcare, and O'Grady Peyton brands; rapid response nurse staffing and labor disruption services under the NurseChoice and HealthSource Global Staffing brands; local or per diem staffing services under Nursefinders brand; and locum tenens staffing services under the Staff Care and Locum Leaders brands. The company also provides allied health professionals, such as physical therapists, respiratory therapists, occupational therapists, medical and radiology technologists, lab technicians, speech pathologists, rehabilitation assistants, and pharmacists under the Med Travelers and Club Staffing brands; revenue cycle solutions; physician permanent placement services to hospitals, healthcare facilities, and physician practice groups; interim leadership staffing and executive search services; and recruitment process outsourcing services. In addition, it offers managed services programs; language interpretation services; vendor management systems; workforce optimization services; credentialing services; digital staffing services; and flex pool management services. AMN Healthcare Services, Inc. was founded in 1985 and is based in Dallas, Taxas.

Company Website : http://www.amnhealthcare.com

Address : 8840 Cypress Waters Boulevard, Dallas, TX, United States, 75019

Employees : 3,000

Fiscal Year End : December

Currency: USD

Country : USA

Technical Indicators

Beta : 0.40

52 Week High : 117.17

Short Ratio : 2.54

52 Week Low : 55.22

Shorted Shares : 776,448

200 Day Moving Average : 92.84

Shorted Shares Previous Month : 807,229

50 Day Moving Average : 109.74

Shares Held By Insiders : 0.90%

Short Percentage : 2.00%

Shares Held by Institutions : 96.83%

Unadjusted Closing Price

Adjusted Closing Price

Share Volume

Relative Performance (Total Returns)

Compare
Relative Returns (From:    To: 2021-09-22 )

Largest Industry Peers for Medical Care Facilities

Symbol Name Price(Change) Market Cap Price / Earning Ratio EV/EBITDA
HCA HCA Healthcare Inc

+2.41 (+0.94%)

 USD82.64B 17.72 10.03
FMS Fresenius Medical Care AG & Co..

+0.48 (+1.34%)

 USD20.97B 17.90 9.10
DVA DaVita Inc

+1.26 (+1.05%)

 USD12.55B 16.12 10.11
OSH Oak Street Health Inc

+0.34 (+0.68%)

 USD12.14B N/A N/A
UHS Universal Health Services Inc

+0.40 (+0.28%)

 USD12.07B 11.50 7.78
AGL agilon health inc

-0.22 (-0.78%)

 USD11.07B N/A N/A
THC Tenet Healthcare Corporation

+0.65 (+0.90%)

 USD7.69B 31.92 7.36
EHC Encompass Health Corporation

+1.76 (+2.35%)

 USD7.49B 19.61 10.34
CHE Chemed Corporation

+0.02 (+0.00%)

 USD7.44B 25.39 16.85
SEM Select Medical Holdings Corpor..

+0.69 (+1.98%)

 USD4.68B 10.91 7.94

ETFs Containing AMN

Symbol Name Weight Mer Price(Change) Market Cap
ETHO Etho Climate Leadership U.. 0.00 % 0.48 %

+0.64 (+1.06%)

 USD0.17B
IJR iShares Core S&P Small-Ca.. 0.00 % 0.06 %

+1.74 (+1.62%)

 USD68.64B
PRFZ Invesco FTSE RAFI US 1500.. 0.00 % 0.39 %

+2.71 (+1.51%)

 USD2.01B
PSCH Invesco S&P SmallCap Heal.. 0.00 % 0.29 %

+2.00 (+1.09%)

 USD0.53B
SAA ProShares Trust - ProShar.. 0.00 % 0.95 %

+0.91 (+3.18%)

 USD0.05B
SLY SPDR Series Trust - SPDR .. 0.00 % 0.15 %

+1.51 (+1.63%)

 USD1.82B
XHS SPDR Series Trust - SPDR .. 0.00 % 0.35 %

+0.48 (+0.45%)

 USD0.21B
HERS:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

 USD3.37M
GSSC Goldman Sachs ActiveBeta .. 0.00 % 0.20 %

+0.98 (+1.57%)

 USD0.43B
SPSM SPDR Series Trust - SPDR .. 0.00 % 0.05 %

+0.68 (+1.63%)

 USD4.17B
HERS-B:CA Evolve North American Gen.. 0.00 % 0.40 %

N/A

 N/A
IDP6:LSE iShares III Public Limite.. 0.00 % 0.40 %

+1.46 (+1.68%)

 USD1.27B
ISP6:LSE iShares III Public Limite.. 0.00 % 0.40 %

+118.00 (+1.85%)

 USD1.27B
ROSC Hartford Multifactor Smal.. 0.00 % 0.34 %

+0.40 (+1.05%)

 N/A
SMLE DBX ETF Trust - S&P Small.. 0.00 % 0.15 %

+0.41 (+1.62%)

 N/A
QVMS Invesco Exchange-Traded F.. 0.00 % 0.15 %

+0.38 (+1.61%)

 N/A

Market Performance

  Market Performance vs.
Industry/Classification (Medical Care Facilities)		 Market Performance vs. Exchange
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
YTD  
Capital Gain 67.75% 84% B 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 67.75% 84% B 94% A
Trailing 12 Months  
Capital Gain 115.90% 68% D+ 90% A-
Dividend Return N/A N/A N/A N/A N/A
Total Return 115.90% 68% D+ 90% A-
Trailing 5 Years  
Capital Gain 244.85% 100% A+ 94% A
Dividend Return N/A N/A N/A N/A N/A
Total Return 244.85% 93% A 94% A
Average Annual (5 Year Horizon)  
Capital Gain 25.30% 68% D+ 86% B
Dividend Return N/A N/A N/A N/A N/A
Total Return 25.30% 68% D+ 84% B
Risk Return Profile  
Volatility (Standard Deviation) 34.60% 58% F 31% F
Risk Adjusted Return 73.12% 84% B 78% C+
Market Capitalization 5.19B 61% D- 74% C
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 87%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Key Financial Ratios

  Ratio vs. Industry/Classification
(Medical Care Facilities)		 Ratio vs. Market
  Value Sector Median Percentile Rank Grade Market Median Percentile Rank Grade
Market Value  
Price / Earning Ratio 46.20 22% F 16% F
Price/Book Ratio 5.48 47% F 18% F
Price / Cash Flow Ratio 20.20 4% F 22% F
EV/EBITDA 16.05 39% F 36% F
Management Effectiveness  
Return on Equity 1,978.72% 95% A 95% A
Return on Invested Capital 8.46% 57% F 71% C-
Return on Assets 7.02% 76% C 85% B
Debt to Equity Ratio 104.67% 56% F 35% F
Technical Ratios  
Short Ratio 2.54 78% C+ 50% F
Short Percent 1.66% 78% C+ 66% D
Beta 0.40 84% B 86% B
Letter Grade Percentage Letter Grade Percentage Letter Grade Percentage
A+ 97%-100% A 93%-96% A- 90%-92%
B+ 97%-89% B 83%-86% B- 80%-82%
C+ 77%-79% C 73%-76% C- 70%-72%
D+ 67%-69% D 63%-66% D- 60%-62%
F 0%-59%

Annual Financials (USD)

Quarterly Financials (USD)

Analyst Ratings

Target Price Action Rating Action Analyst Rating Price Date

No discussions yet

User / Independent Analyst Ratings

User Name Target Rating Target Horizon (Months) Target Price User Analysis Date Comment

Fundamental Analysis Breakdown

This is a composite scorecard based on the application of evaluation criteria deemed most important by analysts. This is not a buy or sell recommendation.

What to like:
Superior risk adjusted returns

This stock has performed well, on a risk adjusted basis, compared to its sector peers(for a hold period of at least 12 months) and is in the top quartile.

Superior return on equity

The company management has delivered better return on equity in the most recent 4 quarters then its peers, placing it in the top quartile.

Superior return on assets

The company management has delivered better return on assets in the most recent 4 quarters than its peers, placing it in the top quartile.

Positive cash flow

The company had positive total cash flow in the most recent four quarters.

Positive free cash flow

The company had positive total free cash flow in the most recent four quarters.

Superior Revenue Growth

This stock has shown top quartile revenue growth in the previous 5 years compared to its sector.

What to not like:
Overpriced compared to earnings

The stock is trading high compared to its peers on a price to earning basis and is above the sector median.

Overpriced compared to book value

The stock is trading high compared to its peers median on a price to book value basis.

Overpriced on cashflow basis

The stock is trading high compared to its peers on a price to cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Overpriced on free cash flow basis

The stock is trading high compared to its peers on a price to free cash flow basis. It is priced above the median for its sectors. Proceed with caution if you are considering to buy.

Low Earnings Growth

This stock has shown below median earnings growth in the previous 5 years compared to its sector